Magnitude Biosciences raises £1.3m led by Northstar Ventures to run drug discovery screens in living nematode worms

Magnitude Biosciences is a contract research organisation (CRO) based in Sedgefield, UK, specialising in in vivo drug discovery using C.elegans. Its patented WormGazer® technology and VivoScan™ platform provides rapid, high-quality data on compound efficacy, toxicity, and mechanism of action - helping biotech and pharma companies make better decisions, faster. With over 120 projects delivered, Magnitude is trusted by clients in drug discovery, health and nutrition, and ageing biology.